PMID- 27848024
OWN - NLM
STAT- MEDLINE
DCOM- 20171107
LR  - 20191210
IS  - 1435-1250 (Electronic)
IS  - 0340-1855 (Linking)
VI  - 76
IP  - 2
DP  - 2017 Mar
TI  - [Current guidelines on ANCA-associated vasculitides : Common features and 
      differences].
PG  - 133-142
LID - 10.1007/s00393-016-0223-y [doi]
AB  - The results of a number of prospective randomized controlled clinical trials have 
      led to changes in established strategies for the treatment of antineutrophil 
      cytoplasmic antibody (ANCA) associated vasculitides (AAV) in recent years. Since 
      2014, a total of 4 scientific societies and study groups have systematically 
      reviewed the new data and have formulated evidence-based recommendations for the 
      management of AAV based on the analysis. These recommendations contain 
      information on diagnosis, treatment (induction and maintenance), supportive care 
      and monitoring of disease activity and resulting damage. This review compares the 
      recently published recommendations of the German Society of Rheumatology 
      (Deutschen Gesellschaft fur Rheumatologie, DGRh), the European League Against 
      Rheumatism (EULAR)/European Renal Association (ERA), the British Society of 
      Rheumatology (BSR) and the Canadian Vasculitis Research Network (CanVasc). The 
      comparative analysis reveals a high level of agreement on numerous topics but 
      also shows some minor and even a few major differences in the respective 
      recommended approach to diagnosis and treatment of AAV. Divergent recommendations 
      predominantly exist in areas with little scientific evidence from clinical 
      studies. Furthermore, some differences result from different interpretation of 
      existing data or are influenced by characteristic features of the respective 
      national healthcare system.
FAU - Hellmich, B
AU  - Hellmich B
AD  - Vaskulitiszentrum Sud, Klinik fur Innere Medizin, Rheumatologie und Immunologie, 
      Klinik Kirchheim, Akademisches Lehrkrankenhaus der Universitat Tubingen, 
      Eugenstr. 3, 73230, Kirchheim u. Teck, Deutschland. b.hellmich@kk-es.de.
LA  - ger
PT  - Comparative Study
PT  - Evaluation Study
PT  - Journal Article
PT  - Review
TT  - Aktuelle Leitlinien zu ANCA-assoziierten Vaskulitiden : Gemeinsamkeiten und 
      Unterschiede.
PL  - Germany
TA  - Z Rheumatol
JT  - Zeitschrift fur Rheumatologie
JID - 0414162
SB  - IM
MH  - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*diagnosis/*therapy
MH  - Canada
MH  - Clinical Decision-Making/methods
MH  - European Union
MH  - Evidence-Based Medicine/*standards
MH  - Germany
MH  - Humans
MH  - Outcome Assessment, Health Care/standards
MH  - *Practice Guidelines as Topic
MH  - Rheumatology/*standards
MH  - Treatment Outcome
MH  - United Kingdom
OTO - NOTNLM
OT  - Diagnosis
OT  - Evidence
OT  - Recommendations
OT  - Studies
OT  - Treatment
EDAT- 2016/11/17 06:00
MHDA- 2017/11/08 06:00
CRDT- 2016/11/17 06:00
PHST- 2016/11/17 06:00 [pubmed]
PHST- 2017/11/08 06:00 [medline]
PHST- 2016/11/17 06:00 [entrez]
AID - 10.1007/s00393-016-0223-y [pii]
AID - 10.1007/s00393-016-0223-y [doi]
PST - ppublish
SO  - Z Rheumatol. 2017 Mar;76(2):133-142. doi: 10.1007/s00393-016-0223-y.